Brugada Syndrome or Brugada Electrocardiogram?  by van den Berg, Maarten P. et al.
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Erugada Syndrome or
rugada Electrocardiogram?
e read with great interest the paper by Benito et al. (1) from the
rugada group. The authors confirm that important differences
xist between men and women regarding the clinical picture and
utcome in patients with Brugada syndrome. In general, in men
he clinical picture appears more severe and the outcome is worse.
lthough this may seem presumptuous, we wonder if all subjects
n this study truly had Brugada syndrome, in particular the women.
rom the paper, it reads as if the diagnosis “Brugada syndrome” is
ynonymous with the presence of a type-1 electrocardiogram
ECG) (coved-type, either spontaneously or after pharmacologic
rovocation with a sodium-channel blocker). It is not mentioned
hether additional clinical features were required for the diagnosis.
ccording to the consensus statement (2), in addition to a
Brugada ECG” (type-1 ECG), for Brugada syndrome to be
efinitely diagnosed at least 1 of the following clinical features is
equired: documented ventricular fibrillation or polymorphic ven-
ricular tachycardia, a family history of sudden death at 45 years
f age, coved-type ECGs in family members, inducibility of
entricular tachycardia with programmed electrical stimulation,
yncope, or nocturnal agonal respiration. In other words, a Bru-
ada ECG is not sufficient to diagnose Brugada syndrome, and
his is a very important point both in clinical practice and in
cientific studies. When applying the above criteria to the study by
enito et al. (1), some uncertainty remains. According to Table 2
n their paper (1), in women syncope was present “only” in 15%,
borted sudden cardiac death in 1%, a history of sudden cardiac
eath in 45%, and programmed electrical stimulation was per-
ormed in 81% with inducibility in 12%. If anything, these figures
o not add up to 100%. Of note, there was also a difference in the
aseline ECG; as many as 62% of the women had a normal or
ype-3 ECG as opposed to only 25% of the men. Obviously, in
ubjects in whom the diagnosis of Brugada syndrome is not firmly
stablished, a mild clinical picture and a good outcome can be
xpected.
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e thank Dr. van den Berg and colleagues for their interest in our
rticle (1) and their valuable comments, which raise important
ssues regarding the diagnosis of Brugada syndrome. Indeed, a
yndrome requires a constellation of symptoms and signs for
iagnosis, and a single electrocardiographic finding does not define
syndrome. Dr. van den Berg and colleagues do certainly realize
hat Brugada syndrome is no longer a syndrome but a disease.
fter the description of the first mutation in the sodium channel
ausing Brugada syndrome (2), a multitude of other mutations in
he sodium and other channels have been described. It is clear that
he consensus report from 2005 (3) is more than outdated and an
pdate is urgently required in terms of both diagnosis and
herapeutic approach.
The definite phenotypic manifestation of the Brugada syndrome
s the presence of a type-1 electrocardiogram (ECG), either
pontaneously or after sodium-blocker challenge. Given that even
he sole presence of the ECG pattern has been proven to entail a
isk of sudden cardiac death, this was the only prerequisite required
n all of our 384 patients included in the study, as stated in the
rticle (1). However, in reply to Dr. van den Berg and colleagues,
e must say that most of our patients, both men and women and
n similar proportions (82.4% vs. 89.3%, respectively, p  0.06),
id fulfill the II Consensus Report definition of Brugada syn-
rome. Therefore, the better prognosis in women cannot be
xplained because of their lower rate of “confirmed diagnosis”
ccording to the consensus. As can be drawn from our article, in
ddition to the type-1 ECG, 66 of the 272 male patients (24.3%)
lso had symptoms, 82 (30.1%) had a family history of early
udden death, and 84 (31.9%) had documented ventricular fibril-
ation either spontaneous or inducible at the time of diagnosis.
ecause these clinical variables tended to meet within the same
ndividual, they resulted in a total of 148 (54.4%) patients.
dditionally, in 74 (27.2%) more men, a type-1 ECG was
ocumented in at least 1 family member. Therefore, at the time of
heir first evaluation, 222 of 272 patients (81.7%) had a confirmed
iagnosis of Brugada syndrome according to the II Consensus
efinition. On the other hand, a total of 100 of 112 female patients
89.3%) fulfilled the Consensus criteria of Brugada syndrome (62
55.4%] because of symptoms, family history of sudden death,
ocumented ventricular fibrillation, or a combination, and 38
33.9%] because of none of the others and a presence of type-1
CG in family members). Importantly, among the 62 patients (50
en and 12 women) who did not meet the II Consensus definition
